Emily McCourt
Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinopathy of Prematurity | 14 | 2026 | 183 | 2.900 |
Why?
| | Keratoconus | 4 | 2025 | 23 | 2.560 |
Why?
| | Cornea | 3 | 2025 | 156 | 1.720 |
Why?
| | Down Syndrome | 5 | 2025 | 529 | 1.320 |
Why?
| | Corneal Topography | 4 | 2025 | 25 | 1.310 |
Why?
| | Cataract | 6 | 2025 | 240 | 1.200 |
Why?
| | Visual Acuity | 7 | 2026 | 499 | 1.140 |
Why?
| | Corneal Diseases | 3 | 2018 | 48 | 1.130 |
Why?
| | Tomography | 2 | 2025 | 44 | 1.080 |
Why?
| | Vision Disorders | 3 | 2025 | 179 | 1.040 |
Why?
| | Anesthesia, General | 2 | 2025 | 124 | 1.010 |
Why?
| | Conjunctival Diseases | 2 | 2017 | 23 | 1.010 |
Why?
| | Eye Injuries | 2 | 2018 | 53 | 0.920 |
Why?
| | Cataract Extraction | 3 | 2025 | 120 | 0.880 |
Why?
| | Neonatal Screening | 6 | 2026 | 185 | 0.870 |
Why?
| | Patient Positioning | 1 | 2025 | 73 | 0.840 |
Why?
| | Retinal Diseases | 2 | 2025 | 102 | 0.830 |
Why?
| | Pyrimidinones | 1 | 2025 | 124 | 0.820 |
Why?
| | Birth Weight | 9 | 2024 | 521 | 0.790 |
Why?
| | Cranial Nerve Diseases | 2 | 2020 | 42 | 0.770 |
Why?
| | Pyridones | 1 | 2025 | 210 | 0.760 |
Why?
| | Social Media | 1 | 2025 | 159 | 0.750 |
Why?
| | Epithelium, Corneal | 2 | 2024 | 41 | 0.750 |
Why?
| | Developmental Disabilities | 2 | 2025 | 281 | 0.700 |
Why?
| | Eye Diseases | 2 | 2020 | 100 | 0.700 |
Why?
| | Uveitis | 2 | 2026 | 152 | 0.660 |
Why?
| | Gestational Age | 14 | 2026 | 990 | 0.660 |
Why?
| | Pontine Tegmentum | 1 | 2020 | 4 | 0.660 |
Why?
| | Infant | 24 | 2026 | 10114 | 0.650 |
Why?
| | Cerebellar Diseases | 1 | 2020 | 27 | 0.640 |
Why?
| | Retrospective Studies | 29 | 2026 | 17438 | 0.630 |
Why?
| | Stevens-Johnson Syndrome | 2 | 2018 | 37 | 0.630 |
Why?
| | Nervous System Malformations | 1 | 2020 | 47 | 0.620 |
Why?
| | Child, Preschool | 16 | 2026 | 11913 | 0.620 |
Why?
| | Infant, Very Low Birth Weight | 4 | 2019 | 74 | 0.620 |
Why?
| | Retinal Detachment | 2 | 2025 | 74 | 0.580 |
Why?
| | Protein Kinase Inhibitors | 1 | 2025 | 983 | 0.550 |
Why?
| | Vitrectomy | 1 | 2018 | 74 | 0.540 |
Why?
| | Infant, Newborn | 17 | 2026 | 6460 | 0.540 |
Why?
| | Serum | 1 | 2018 | 58 | 0.540 |
Why?
| | Endophthalmitis | 2 | 2026 | 46 | 0.530 |
Why?
| | Ophthalmic Solutions | 1 | 2018 | 82 | 0.530 |
Why?
| | Eye Infections, Bacterial | 2 | 2026 | 46 | 0.520 |
Why?
| | Child | 21 | 2026 | 22693 | 0.520 |
Why?
| | Farber Lipogranulomatosis | 1 | 2017 | 4 | 0.520 |
Why?
| | Infant, Low Birth Weight | 2 | 2017 | 154 | 0.510 |
Why?
| | Coccyx | 1 | 2017 | 4 | 0.500 |
Why?
| | Amnion | 1 | 2017 | 31 | 0.500 |
Why?
| | Choroid Neoplasms | 1 | 2017 | 9 | 0.500 |
Why?
| | Synovitis | 1 | 2017 | 35 | 0.500 |
Why?
| | Cicatrix | 1 | 2017 | 72 | 0.480 |
Why?
| | Arthritis | 1 | 2017 | 97 | 0.470 |
Why?
| | Sacrum | 1 | 2017 | 80 | 0.470 |
Why?
| | Tomography, Optical Coherence | 2 | 2025 | 283 | 0.460 |
Why?
| | Teratoma | 1 | 2017 | 121 | 0.450 |
Why?
| | Streptococcal Infections | 2 | 2026 | 179 | 0.450 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 113 | 0.450 |
Why?
| | Humans | 56 | 2026 | 146342 | 0.430 |
Why?
| | Glaucoma | 3 | 2025 | 267 | 0.410 |
Why?
| | Algorithms | 4 | 2018 | 1849 | 0.410 |
Why?
| | Female | 37 | 2026 | 79499 | 0.410 |
Why?
| | Adolescent | 14 | 2026 | 22557 | 0.410 |
Why?
| | Bone Neoplasms | 1 | 2017 | 272 | 0.410 |
Why?
| | Hyphema | 1 | 2013 | 7 | 0.400 |
Why?
| | Infant, Premature | 6 | 2026 | 622 | 0.380 |
Why?
| | Colorado | 11 | 2026 | 4595 | 0.380 |
Why?
| | Male | 30 | 2026 | 73396 | 0.370 |
Why?
| | Cryoglobulinemia | 1 | 2012 | 5 | 0.350 |
Why?
| | Vision, Low | 1 | 2012 | 16 | 0.350 |
Why?
| | Retinal Vasculitis | 1 | 2012 | 12 | 0.350 |
Why?
| | Risk Factors | 12 | 2026 | 10921 | 0.320 |
Why?
| | Dacryocystitis | 1 | 2010 | 5 | 0.320 |
Why?
| | Mucocele | 1 | 2010 | 12 | 0.320 |
Why?
| | Choroid | 1 | 2010 | 81 | 0.310 |
Why?
| | Retinal Neoplasms | 1 | 2010 | 47 | 0.310 |
Why?
| | Hepatitis C, Chronic | 1 | 2012 | 150 | 0.310 |
Why?
| | Retinoblastoma | 1 | 2010 | 53 | 0.300 |
Why?
| | Cytomegalovirus Retinitis | 2 | 2022 | 22 | 0.300 |
Why?
| | Porencephaly | 2 | 2019 | 6 | 0.300 |
Why?
| | Ophthalmology | 2 | 2022 | 122 | 0.290 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2010 | 132 | 0.290 |
Why?
| | Fluorescein Angiography | 2 | 2025 | 197 | 0.290 |
Why?
| | Mutation | 6 | 2026 | 4093 | 0.290 |
Why?
| | Laser Coagulation | 3 | 2026 | 80 | 0.280 |
Why?
| | Streptococcus agalactiae | 1 | 2010 | 118 | 0.280 |
Why?
| | Incidence | 5 | 2022 | 2936 | 0.270 |
Why?
| | Macular Degeneration | 1 | 2010 | 196 | 0.270 |
Why?
| | Diabetic Retinopathy | 1 | 2010 | 211 | 0.270 |
Why?
| | Tertiary Care Centers | 2 | 2026 | 196 | 0.250 |
Why?
| | Diagnostic Techniques, Ophthalmological | 2 | 2018 | 55 | 0.250 |
Why?
| | Blepharitis | 1 | 2026 | 8 | 0.230 |
Why?
| | Keratoconjunctivitis | 1 | 2026 | 11 | 0.230 |
Why?
| | Streptococcus pyogenes | 1 | 2026 | 41 | 0.230 |
Why?
| | Oligonucleotides, Antisense | 1 | 2026 | 122 | 0.230 |
Why?
| | Receptors, Virus | 1 | 2026 | 91 | 0.230 |
Why?
| | Aphakia, Postcataract | 1 | 2025 | 13 | 0.230 |
Why?
| | Retina | 2 | 2026 | 330 | 0.220 |
Why?
| | Weight Gain | 3 | 2019 | 562 | 0.220 |
Why?
| | Rare Diseases | 1 | 2026 | 117 | 0.220 |
Why?
| | Microscopy, Acoustic | 2 | 2018 | 10 | 0.220 |
Why?
| | Riboflavin | 1 | 2025 | 15 | 0.220 |
Why?
| | Corneal Stroma | 1 | 2025 | 24 | 0.220 |
Why?
| | Photochemotherapy | 1 | 2025 | 39 | 0.220 |
Why?
| | Photosensitizing Agents | 1 | 2025 | 42 | 0.210 |
Why?
| | Membrane Transport Proteins | 1 | 2026 | 154 | 0.210 |
Why?
| | Angiogenesis Inhibitors | 1 | 2026 | 239 | 0.210 |
Why?
| | Cross-Linking Reagents | 1 | 2025 | 208 | 0.200 |
Why?
| | Diseases in Twins | 1 | 2024 | 115 | 0.200 |
Why?
| | Genetic Therapy | 1 | 2026 | 303 | 0.200 |
Why?
| | Hospitals, Pediatric | 3 | 2026 | 561 | 0.200 |
Why?
| | Young Adult | 6 | 2025 | 14330 | 0.200 |
Why?
| | Twins | 1 | 2024 | 156 | 0.200 |
Why?
| | Corneal Injuries | 1 | 2024 | 42 | 0.200 |
Why?
| | Specialties, Surgical | 1 | 2025 | 88 | 0.200 |
Why?
| | ROC Curve | 3 | 2026 | 617 | 0.200 |
Why?
| | Lens, Crystalline | 1 | 2025 | 136 | 0.200 |
Why?
| | Xanthomatosis, Cerebrotendinous | 1 | 2023 | 5 | 0.200 |
Why?
| | Ophthalmologists | 1 | 2023 | 21 | 0.200 |
Why?
| | Galactosemias | 1 | 2023 | 16 | 0.200 |
Why?
| | Physicians, Women | 1 | 2025 | 92 | 0.200 |
Why?
| | Refractive Errors | 1 | 2023 | 36 | 0.190 |
Why?
| | Arachnoid Cysts | 1 | 2023 | 10 | 0.190 |
Why?
| | Vision Screening | 1 | 2023 | 48 | 0.190 |
Why?
| | Amblyopia | 1 | 2023 | 60 | 0.190 |
Why?
| | Collagen Type IV | 2 | 2019 | 26 | 0.180 |
Why?
| | Collagen | 1 | 2025 | 460 | 0.180 |
Why?
| | Papilledema | 1 | 2023 | 44 | 0.180 |
Why?
| | Milk, Human | 1 | 2024 | 176 | 0.180 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 846 | 0.180 |
Why?
| | Neurodevelopmental Disorders | 1 | 2025 | 239 | 0.170 |
Why?
| | Physical Examination | 2 | 2023 | 237 | 0.170 |
Why?
| | Ophthalmoscopy | 2 | 2018 | 38 | 0.170 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2022 | 130 | 0.170 |
Why?
| | Mice, Inbred BALB C | 1 | 2024 | 1244 | 0.170 |
Why?
| | Wound Healing | 1 | 2024 | 354 | 0.170 |
Why?
| | Vigabatrin | 1 | 2021 | 19 | 0.170 |
Why?
| | Corneal Pachymetry | 1 | 2020 | 16 | 0.160 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2026 | 427 | 0.160 |
Why?
| | Surgeons | 1 | 2025 | 351 | 0.150 |
Why?
| | Cytomegalovirus | 2 | 2022 | 172 | 0.150 |
Why?
| | Energy Metabolism | 1 | 2026 | 930 | 0.150 |
Why?
| | Legislation, Drug | 1 | 2020 | 73 | 0.150 |
Why?
| | Cross-Sectional Studies | 4 | 2025 | 5899 | 0.150 |
Why?
| | Specialization | 1 | 2020 | 137 | 0.150 |
Why?
| | Remission, Spontaneous | 1 | 2019 | 39 | 0.140 |
Why?
| | Retinal Hemorrhage | 1 | 2019 | 21 | 0.140 |
Why?
| | Mitochondria | 1 | 2026 | 997 | 0.140 |
Why?
| | Face | 1 | 2020 | 177 | 0.140 |
Why?
| | Anticonvulsants | 1 | 2021 | 253 | 0.140 |
Why?
| | Cohort Studies | 6 | 2020 | 6077 | 0.140 |
Why?
| | Intracranial Hypertension | 1 | 2019 | 42 | 0.140 |
Why?
| | Medical Marijuana | 1 | 2020 | 120 | 0.140 |
Why?
| | Intracranial Pressure | 1 | 2019 | 64 | 0.140 |
Why?
| | Fluorometholone | 1 | 2017 | 4 | 0.130 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 195 | 0.130 |
Why?
| | Hereditary Autoinflammatory Diseases | 1 | 2017 | 13 | 0.130 |
Why?
| | Perception | 1 | 2020 | 373 | 0.130 |
Why?
| | North America | 1 | 2018 | 300 | 0.130 |
Why?
| | Nod2 Signaling Adaptor Protein | 1 | 2017 | 34 | 0.120 |
Why?
| | Labor, Induced | 1 | 2017 | 41 | 0.120 |
Why?
| | Marijuana Smoking | 1 | 2020 | 249 | 0.120 |
Why?
| | Labor, Obstetric | 1 | 2017 | 67 | 0.120 |
Why?
| | Cell Proliferation | 1 | 2024 | 2502 | 0.120 |
Why?
| | Marijuana Use | 1 | 2020 | 218 | 0.120 |
Why?
| | Electronic Health Records | 1 | 2025 | 1210 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 582 | 0.120 |
Why?
| | Treatment Outcome | 5 | 2026 | 11821 | 0.110 |
Why?
| | Household Products | 1 | 2015 | 6 | 0.110 |
Why?
| | Burnout, Professional | 1 | 2022 | 493 | 0.110 |
Why?
| | Mothers | 2 | 2018 | 772 | 0.110 |
Why?
| | Eye Burns | 1 | 2015 | 14 | 0.110 |
Why?
| | Xerophthalmia | 1 | 2014 | 7 | 0.110 |
Why?
| | Sarcoidosis | 1 | 2017 | 164 | 0.110 |
Why?
| | Vitamin A Deficiency | 1 | 2014 | 23 | 0.110 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 320 | 0.110 |
Why?
| | Burns, Chemical | 1 | 2015 | 32 | 0.110 |
Why?
| | Adult | 7 | 2025 | 41087 | 0.110 |
Why?
| | Corneal Ulcer | 1 | 2014 | 21 | 0.110 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2015 | 81 | 0.110 |
Why?
| | DNA, Viral | 1 | 2016 | 354 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2026 | 1957 | 0.100 |
Why?
| | Homocystinuria | 1 | 2015 | 62 | 0.100 |
Why?
| | Diagnosis, Differential | 2 | 2026 | 1503 | 0.100 |
Why?
| | Accidents, Home | 1 | 2013 | 32 | 0.100 |
Why?
| | Sensitivity and Specificity | 4 | 2023 | 1998 | 0.100 |
Why?
| | Telangiectasis | 1 | 2013 | 7 | 0.100 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4580 | 0.100 |
Why?
| | Skin Diseases, Vascular | 1 | 2013 | 8 | 0.100 |
Why?
| | Physicians | 1 | 2022 | 955 | 0.100 |
Why?
| | Premature Birth | 1 | 2017 | 390 | 0.090 |
Why?
| | Glucocorticoids | 1 | 2017 | 536 | 0.090 |
Why?
| | DNA | 1 | 2019 | 1421 | 0.090 |
Why?
| | Placenta | 1 | 2018 | 794 | 0.080 |
Why?
| | Intraocular Pressure | 1 | 2013 | 344 | 0.080 |
Why?
| | Time Factors | 2 | 2019 | 7109 | 0.080 |
Why?
| | Fovea Centralis | 1 | 2010 | 24 | 0.080 |
Why?
| | Eye Enucleation | 1 | 2010 | 16 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 3 | 2019 | 3926 | 0.080 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2016 | 704 | 0.080 |
Why?
| | Decompression, Surgical | 1 | 2010 | 115 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2026 | 5439 | 0.070 |
Why?
| | Functional Laterality | 1 | 2010 | 242 | 0.070 |
Why?
| | Postoperative Complications | 2 | 2025 | 3034 | 0.070 |
Why?
| | Severity of Illness Index | 2 | 2026 | 2921 | 0.060 |
Why?
| | Inflammation | 1 | 2018 | 2919 | 0.060 |
Why?
| | United States | 5 | 2026 | 16136 | 0.060 |
Why?
| | Intravitreal Injections | 1 | 2026 | 73 | 0.060 |
Why?
| | Pseudophakia | 1 | 2025 | 21 | 0.060 |
Why?
| | Bevacizumab | 1 | 2026 | 169 | 0.060 |
Why?
| | Nystagmus, Pathologic | 1 | 2025 | 16 | 0.060 |
Why?
| | Refraction, Ocular | 1 | 2025 | 47 | 0.060 |
Why?
| | Myopia | 1 | 2025 | 59 | 0.050 |
Why?
| | Strabismus | 1 | 2025 | 71 | 0.050 |
Why?
| | Re-Epithelialization | 1 | 2024 | 6 | 0.050 |
Why?
| | Cholestanol | 1 | 2023 | 4 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2024 | 334 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2026 | 545 | 0.050 |
Why?
| | Rupture | 1 | 2023 | 91 | 0.050 |
Why?
| | Ganciclovir | 1 | 2022 | 51 | 0.050 |
Why?
| | Ultraviolet Rays | 1 | 2025 | 376 | 0.040 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 163 | 0.040 |
Why?
| | Dexamethasone | 1 | 2024 | 368 | 0.040 |
Why?
| | Electroretinography | 1 | 2021 | 51 | 0.040 |
Why?
| | Zebrafish | 1 | 2026 | 536 | 0.040 |
Why?
| | Fibroblasts | 1 | 2026 | 1034 | 0.040 |
Why?
| | Growth Charts | 1 | 2019 | 20 | 0.040 |
Why?
| | Syndrome | 1 | 2020 | 380 | 0.040 |
Why?
| | Anthropometry | 1 | 2019 | 204 | 0.040 |
Why?
| | Area Under Curve | 1 | 2019 | 335 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2107 | 0.040 |
Why?
| | Risk Assessment | 2 | 2019 | 3712 | 0.030 |
Why?
| | Immunity, Maternally-Acquired | 1 | 2018 | 18 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2019 | 410 | 0.030 |
Why?
| | Pedigree | 1 | 2019 | 512 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2010 | 8391 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2023 | 2113 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2026 | 1107 | 0.030 |
Why?
| | Parity | 1 | 2017 | 113 | 0.030 |
Why?
| | Craniocerebral Trauma | 1 | 2019 | 173 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 779 | 0.030 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2016 | 24 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2861 | 0.030 |
Why?
| | Registries | 1 | 2024 | 2400 | 0.030 |
Why?
| | Risk | 1 | 2018 | 920 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2023 | 3416 | 0.030 |
Why?
| | Transplantation, Homologous | 1 | 2016 | 416 | 0.030 |
Why?
| | Optic Atrophy | 1 | 2015 | 8 | 0.030 |
Why?
| | Nutrition Disorders | 1 | 2014 | 21 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2026 | 1942 | 0.030 |
Why?
| | Disease Progression | 1 | 2022 | 2867 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 7230 | 0.030 |
Why?
| | Hematologic Neoplasms | 1 | 2016 | 170 | 0.030 |
Why?
| | Viral Load | 1 | 2016 | 526 | 0.030 |
Why?
| | Photography | 1 | 2014 | 120 | 0.030 |
Why?
| | Awards and Prizes | 1 | 2014 | 72 | 0.020 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2017 | 295 | 0.020 |
Why?
| | Livedo Reticularis | 1 | 2013 | 4 | 0.020 |
Why?
| | Fetus | 1 | 2018 | 800 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1031 | 0.020 |
Why?
| | Animals | 2 | 2026 | 38107 | 0.020 |
Why?
| | Autistic Disorder | 1 | 2014 | 216 | 0.020 |
Why?
| | Models, Statistical | 1 | 2016 | 669 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3206 | 0.020 |
Why?
| | Aged | 1 | 2010 | 26432 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 6073 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1761 | 0.020 |
Why?
| | Middle Aged | 1 | 2010 | 36619 | 0.020 |
Why?
| | Mice | 1 | 2024 | 18297 | 0.020 |
Why?
| | Brain | 1 | 2019 | 2991 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 8123 | 0.010 |
Why?
|
|
McCourt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|